0001485003-16-000050.txt : 20160229 0001485003-16-000050.hdr.sgml : 20160229 20160229171124 ACCESSION NUMBER: 0001485003-16-000050 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160225 FILED AS OF DATE: 20160229 DATE AS OF CHANGE: 20160229 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eleven Biotherapeutics, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 252025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-871-9911 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Celniker Abbie CENTRAL INDEX KEY: 0001590250 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36296 FILM NUMBER: 161469418 MAIL ADDRESS: STREET 1: C/O ELEVEN BIOTHERAPEUTICS, INC. STREET 2: 215 FIRST STREET, SUITE 400 CITY: CAMBRIDGE STATE: MA ZIP: 02142 4 1 wf-form4_145678385663428.xml FORM 4 X0306 4 2016-02-25 0 0001485003 Eleven Biotherapeutics, Inc. EBIO 0001590250 Celniker Abbie C/O ELEVEN BIOTHERAPEUTICS, INC., 215 FIRST STREET, SUITE 400 CAMBRIDGE MA 02142 1 1 0 0 President and CEO Stock Option (Right to Buy) 0.28 2016-02-25 4 A 0 113250 0 A 2026-02-24 Common Stock 113250.0 113250 D Stock Option (Right to Buy) 0.28 2016-02-25 4 A 0 90000 0 A 2026-02-24 Common Stock 90000.0 90000 D This option was granted February 25, 2016 and vests over four years in equal quarterly installments, with the first installment vesting on March 31, 2016. This option was granted on February 25, 2016 and vests over two years in equal monthly installments, with the first installment vesting on March 25, 2016. /s/ John J. McCabe as attorney-in-fact 2016-02-29